Medical Oncologist
CION Cancer Clinics
How cholangiocarcinoma differs from hepatocellular carcinoma | CION Cancer Clinics
HCC starts in the main liver cells and usually grows in a liver already scarred by cirrhosis or hepatitis. Cholangiocarcinoma starts in the bile duct cells and often grows in a liver that looked normal. They look different on scans, are confirmed in different ways and are treated with different medicines. This page explains each difference and what it means for the questions you ask. At CION Cancer Clinics in Hyderabad, our oncologists explain liver cancer in plain words and plan care around you and your family.
NG
Medically reviewed by Dr. Naresh GunduConsultant Medical Oncologist · MBBS, DNB (Internal Medicine), DM (Medical Oncology, AIIMS) · last reviewed October 2026, next review due October 2027
17+specialists on panel
15,000+patients treated
35+centres across Telangana & AP
4.8★ / 800+Google rating
On this page
- What is the difference between cholangiocarcinoma and HCC?
- How do the two cancers differ in practice?
- How do doctors tell which one it is?
- What do the words on the report mean?
- What do families often believe about these two cancers?
- What this page cannot tell you
- Common questions about cholangiocarcinoma and HCC
The short answer
What is the difference between cholangiocarcinoma and HCC?
Both start in the liver, but from different cells. Hepatocellular carcinoma (HCC) starts in the main liver cells and usually grows in a liver already damaged by cirrhosis or hepatitis. Cholangiocarcinoma starts in the cells lining the bile ducts and often grows in a liver that otherwise looked normal.
Why two cancers in one organ behave so differently
The liver does two jobs with two kinds of cell. Hepatocytes, the main liver cells, do the chemistry: they clean the blood, make proteins and store energy. Bile duct cells line the small pipes that carry bile out of the liver. A cancer keeps the habits of the cell it came from, so the two cancers look different on scans, under the microscope and in their response to medicines.
Why the difference matters to you
The tests used to confirm each one differ. The treatments differ. Even the questions to ask the doctor differ. If a report simply says "liver cancer" or "liver mass", it is fair to ask which of these two it is, or whether it is cancer that spread to the liver from somewhere else, which is the commonest cause of all.
Four real differences
How do the two cancers differ in practice?
The liver around the tumour
HCC almost always grows in a scarred liver. The state of that liver often decides treatment as much as the tumour does. Cholangiocarcinoma more often grows in a liver that works well, which can make larger operations possible.
How each one is found
People with cirrhosis or hepatitis B are offered regular ultrasound checks, so HCC can be found small. No such routine checks exist for most people who get cholangiocarcinoma, so it is often large when first seen.
How each one is confirmed
In a cirrhotic liver, HCC can often be confirmed by a special scan alone. Cholangiocarcinoma nearly always needs a biopsy.
See why a biopsy is needed here but often not for HCC.How each one is treated
Both may be removed by surgery when caught early.
After that, the paths split
- HCC: ablation, TACE through the blood supply, transplant, and its own drug combinations
- Cholangiocarcinoma: chemotherapy with immunotherapy, and targeted medicines if a gene change is found
Not sure whether this applies to you?
Ask an oncologistHow doctors decide
How do doctors tell which one it is?
The scan pattern
A triple-phase CT or MRI films the liver as dye arrives and leaves. HCC usually lights up early and fades quickly, a pattern called arterial enhancement with washout. Cholangiocarcinoma tends to fill in slowly from the edge.
The blood tests
AFP, a protein made by some liver cancers, is raised in many HCCs. CA 19-9, a marker linked to bile duct and pancreatic cancers, may be raised in cholangiocarcinoma. Neither test is proof on its own, and jaundice or infection can push CA 19-9 up.
The biopsy
A thin needle takes a small core of the tumour. The pathologist looks at the cell type and runs stains that point to where it began. CION arranges the biopsy through accredited partner hospitals.
Ruling out spread from elsewhere
Under the microscope cholangiocarcinoma looks like cancers of the bowel, pancreas and stomach. Doctors may scan or scope those organs first, which is why it is often mistaken for secondary cancer.
The tumour board
Radiologists, pathologists, surgeons and oncologists read all of this together. That shared reading settles the label before the plan is made.
On your report
What do the words on the report mean?
- Hepatocellular carcinoma (HCC)
- Cancer of the main liver cells. The commonest cancer that starts in the liver.
- Intrahepatic cholangiocarcinoma
- Cancer of the bile duct cells, starting inside the liver.
- Adenocarcinoma
- A cancer of gland-forming cells. Cholangiocarcinoma is one, and so are bowel and pancreatic cancers.
- Cirrhosis
- Long-standing scarring of the liver. It is the soil HCC usually grows in.
- LI-RADS
- A scoring system radiologists use to say how likely a liver lump in an at-risk liver is to be HCC.
- Combined HCC-cholangiocarcinoma
- A rare tumour with features of both. It has its own page on combined tumours.
Leave a number, we will call you
One field. No form to fill in, and no charge for the call.
Commonly believed
What do families often believe about these two cancers?
"He never drank, so it cannot be liver cancer."
Alcohol is one cause among many, and it is not a fault. Cholangiocarcinoma often grows in people with no liver disease at all, and HCC also follows hepatitis B and fatty liver.
"A normal AFP means there is no cancer."
Many HCCs and almost all cholangiocarcinomas do not raise AFP. A normal result does not cancel a suspicious scan.
"The medicines for liver cancer will work for both."
Drugs such as sorafenib and lenvatinib are used for HCC, not for cholangiocarcinoma. Cholangiocarcinoma has its own chemotherapy, and its own targeted medicines matched to gene changes.
"A biopsy will make the cancer spread."
The risk of a needle carrying cells along its track is small, and doctors take steps to reduce it. For cholangiocarcinoma the sample is needed to confirm the diagnosis and test for gene changes.
Did you know
Some cholangiocarcinomas inside the liver carry a gene change, such as an FGFR2 fusion or an IDH1 mutation, that a targeted medicine can act on. HCC rarely has a change like this. That is why the biopsy sample should be sent for molecular testing. Some of these medicines are not easily available in India and may only be reached through import or trials.
Being straight with you
What this page cannot tell you
It cannot tell you which cancer you have. Scans can suggest one or the other, but tumours do not always follow the textbook. The answer comes from the scans, the blood tests and the biopsy read together by people who see these cancers often.
It cannot tell you what treatment will suit you
That depends on the size and spread of the tumour, how well your liver works, your general fitness and, for cholangiocarcinoma, the gene result. Two people with the same label can be offered very different plans, and both can be right.
Who this does not apply to
This page is not about cancer that spread to the liver from another organ, about bile duct cancer outside the liver, or about gallbladder cancer. It also does not apply to children, whose liver tumours are a separate field. If your report names one of those, ask your doctor for the page or leaflet that fits it.
CION's tumour board can review reports and scans you already have, so tests are not repeated without a reason.Questions we are asked
Common questions about cholangiocarcinoma and HCC
Which is more common in India?
HCC is the more common of the two primary liver cancers in India, driven largely by hepatitis B, hepatitis C, alcohol and fatty liver. Cholangiocarcinoma is less common but is being recognised more often as scans and pathology improve.
Can I have cirrhosis and still have cholangiocarcinoma?
Yes. Cirrhosis and hepatitis B or C raise the risk of both cancers. That is one reason a lump in a cirrhotic liver that does not look like typical HCC on the scan is usually biopsied rather than assumed.
Is one more serious than the other?
Both are serious, and comparing them in general does not tell you much about one person. What matters most is how early the tumour was found, whether it can be removed and, for HCC, how well the rest of the liver works. Your oncologist can talk you through your own situation.
Is a liver transplant an option for both?
Transplant is an established option for some people with early HCC in a cirrhotic liver. For intrahepatic cholangiocarcinoma it is not a standard treatment and is offered only within research settings abroad. Your team can explain whether it is worth asking about.
Why did my doctor order a CA 19-9 test?
It can support a suspicion of bile duct cancer and help track treatment later. It is not specific, so a raised result is never a diagnosis on its own. Blocked bile and infection can raise it too, so it is best read once the jaundice settles.
Is TACE used for cholangiocarcinoma?
TACE is mainly an HCC treatment, because HCC feeds strongly from the liver's arteries. In cholangiocarcinoma, liver directed treatments are sometimes used in selected people, but the evidence is thinner. Medicines through a drip remain the main treatment when surgery is not possible.
Should my family be tested?
Neither cancer is usually inherited. If HCC followed hepatitis B, household members should be tested for hepatitis B and vaccinated if they are not protected. That is ordinary care for families, not blame.
What should I do with the report I have?
Keep the scans on a disc, the written reports and any biopsy blocks or slides together. Ask whether the cell type is confirmed and whether gene testing has been sent. Call the CION helpline and the tumour board can review what you already hold.
Your Specialists
Meet CION's liver cancer specialists. Bring your scan reports and liver blood tests.
Our medical and surgical oncologists plan liver cancer care together, weighing the tumour and how well your liver works before choosing surgery, a liver-directed procedure or medicines.
Medical Oncologist
Dr. C. Raghavendra Reddy
MBBS(Gold Medal), DNB(General Medicine), DM(Medical Oncology)(Gold Medal)
Medical Oncologist
Dr. Bharati Devi Gorantla
MBBS, MD(General Medicine), DM(Medical Oncology)(Adyar,Chennai), ECMO, MRCP SCE(UK)
Medical Oncologist
Dr. Owais Mohammed
MBBS, MD (General Medicine), DrNB (Medical Oncology), ECMO, MRCP SCE (Medical Oncology) (UK)
Medical Oncologist
Medical Oncologist
Surgical Oncologist
Dr. Muralidhar Muddusetty
MBBS (AIIMS), MS (Surgery) (AIIMS), DNB (Surgical Oncology), MRCS (Edinburgh)
Surgical Oncologist
Want a specific doctor for your case? Mention them when booking.
Book Free ConsultationBook an appointment with our specialist
Share your name and number — we'll call you back within 30 minutes to schedule your consultation.
Sources
- American Cancer Society — What Is Bile Duct Cancer?
- American Cancer Society — What Is Liver Cancer?
- American Cancer Society — Bile Duct Cancer Diagnostic Tests
- National Cancer Institute — Liver Cancer Diagnosis
This page is general information, not a prescription. Do not change or stop any treatment based on what you read here. If anything is worrying you, contact your own treating team — or call our helpline and we will help you reach the right specialist.
Keep reading
Related pages
Hepatocellular carcinoma: what it isThe commoner liver cancer, explained in fullIntrahepatic cholangiocarcinoma: what it isThe bile duct cancer inside the liver, explained in fullWhy a biopsy is needed here but often not for HCCThe next step if a biopsy has been suggestedBile duct cancer inside the liver vs outside itWhere along the ducts it starts, and why that matters
Talk to us
Not sure which liver cancer your report describes?
Share the scans, blood tests and biopsy report you already have. The tumour board can tell you what they point to and what still needs to be checked. One helpline serves every CION centre.